$AGEN
AGENUS INC

2014 Q1 Form 10-K Financial Statement

#000144530514000937 Filed on March 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $721.0K $393.0K $1.090M
YoY Change -34.99% -63.94% 69.25%
Cost Of Revenue $0.00 $10.00K $300.0K
YoY Change -100.0% -96.67%
Gross Profit $721.0K $390.0K $790.0K
YoY Change -13.78% -50.63% 23.44%
Gross Profit Margin 100.0% 99.24% 72.48%
Selling, General & Admin $5.440M $3.370M $2.650M
YoY Change 88.24% 27.17% -2.21%
% of Gross Profit 754.51% 864.1% 335.44%
Research & Development $4.473M $3.240M $2.370M
YoY Change 75.11% 36.71% -17.13%
% of Gross Profit 620.32% 830.77% 300.0%
Depreciation & Amortization $270.0K $140.0K $130.0K
YoY Change 80.0% 7.69% -76.36%
% of Gross Profit 37.45% 35.9% 16.46%
Operating Expenses $4.473M $6.610M $5.020M
YoY Change 75.11% 31.67% -9.87%
Operating Profit -$9.824M -$6.220M -$4.230M
YoY Change 113.14% 47.04% -14.2%
Interest Expense $355.8K -$350.0K -$1.210M
YoY Change -71.04% -71.07% 10.0%
% of Operating Profit
Other Income/Expense, Net $9.822M $800.0K $0.00
YoY Change 340957.85%
Pretax Income -$640.0K -$5.780M -$5.440M
YoY Change -89.04% 6.25% -9.63%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$357.0K -$5.777M -$5.441M
YoY Change -93.88% 6.18% -9.62%
Net Earnings / Revenue -49.51% -1469.97% -499.17%
Basic Earnings Per Share -$0.01 -$0.16 -$0.23
Diluted Earnings Per Share -$10.74K -$161.7K -$0.23
COMMON SHARES
Basic Shares Outstanding 62.17M shares 35.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.50M $27.40M $21.50M
YoY Change 327.33% 27.44% 100.93%
Cash & Equivalents $73.49M $27.35M $21.47M
Short-Term Investments
Other Short-Term Assets $443.8K $163.0K $32.16K
YoY Change 583.3% 406.89% -95.4%
Inventory $0.00 $16.02K
Prepaid Expenses $1.325M $658.4K $545.9K
Receivables $0.00 $1.200K $552.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $75.26M $28.17M $22.61M
YoY Change 310.22% 24.59% 88.39%
LONG-TERM ASSETS
Property, Plant & Equipment $4.136M $2.785M $2.606M
YoY Change 41.86% 6.85% -36.99%
Goodwill $19.64M $2.572M $2.572M
YoY Change 663.38% 0.0% 0.0%
Intangibles $7.998M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.275M $1.304M $1.299M
YoY Change -1.9% 0.35% 18.71%
Total Long-Term Assets $33.04M $6.661M $6.478M
YoY Change 386.88% 2.82% -16.99%
TOTAL ASSETS
Total Short-Term Assets $75.26M $28.17M $22.61M
Total Long-Term Assets $33.04M $6.661M $6.478M
Total Assets $108.3M $34.84M $29.09M
YoY Change 330.92% 19.74% 46.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.681M $834.7K $634.8K
YoY Change 189.13% 31.51% -21.43%
Accrued Expenses $4.699M $4.215M $2.168M
YoY Change 47.06% 94.4% 25.32%
Deferred Revenue
YoY Change
Short-Term Debt $1.200M $0.00 $0.00
YoY Change
Long-Term Debt Due $2.869M $3.519M $204.1K
YoY Change 1324.13% 1624.04% 3.24%
Total Short-Term Liabilities $14.37M $10.30M $4.813M
YoY Change 148.76% 113.92% 1.25%
LONG-TERM LIABILITIES
Long-Term Debt $5.300M $5.300M $35.70M
YoY Change -85.32% -85.15% 9.17%
Other Long-Term Liabilities $2.655M $1.680M $1.365M
YoY Change 80.25% 23.02% 26.4%
Total Long-Term Liabilities $2.655M $1.680M $1.365M
YoY Change 80.25% 23.02% 26.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.37M $10.30M $4.813M
Total Long-Term Liabilities $2.655M $1.680M $1.365M
Total Liabilities $17.03M $11.98M $6.178M
YoY Change 134.85% 93.83% 5.91%
SHAREHOLDERS EQUITY
Retained Earnings -$649.2M -$649.1M -$619.0M
YoY Change 3.89% 4.86% 1.86%
Common Stock $622.3K $363.9K $246.5K
YoY Change 145.52% 47.66% 14.44%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $324.8K $324.8K
YoY Change -100.0% 0.0% 0.0%
Treasury Stock Shares 0.000 shares 43.49K shares 43.49K shares
Shareholders Equity $63.29M -$4.481M -$17.60M
YoY Change
Total Liabilities & Shareholders Equity $108.3M $34.84M $29.09M
YoY Change 330.92% 19.74% 46.88%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$357.0K -$5.777M -$5.441M
YoY Change -93.88% 6.18% -9.62%
Depreciation, Depletion And Amortization $270.0K $140.0K $130.0K
YoY Change 80.0% 7.69% -76.36%
Cash From Operating Activities -$10.12M -$5.540M -$3.280M
YoY Change 159.91% 68.9% -21.53%
INVESTING ACTIVITIES
Capital Expenditures $172.6K -$60.00K $0.00
YoY Change -54.26%
Acquisitions
YoY Change
Other Investing Activities $510.0K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $341.9K -$60.00K $0.00
YoY Change -190.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $55.91M 2.760M -10.00K
YoY Change 304413.53% -27700.0% -105.26%
NET CHANGE
Cash From Operating Activities -$10.12M -5.540M -3.280M
Cash From Investing Activities $341.9K -60.00K 0.000
Cash From Financing Activities $55.91M 2.760M -10.00K
Net Change In Cash $46.13M -2.840M -3.290M
YoY Change -1184.22% -13.68% -17.54%
FREE CASH FLOW
Cash From Operating Activities -$10.12M -$5.540M -$3.280M
Capital Expenditures $172.6K -$60.00K $0.00
Free Cash Flow -$10.30M -$5.480M -$3.280M
YoY Change 141.0% 67.07% -21.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
834740 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
634752 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1200 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
552334 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4215221 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2168338 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1121000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
919000 USD
CY2013Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1635000 USD
CY2012Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
592000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27637443 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27404751 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
595917080 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
644571866 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3335066 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4054561 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4074814 USD
CY2012Q4 us-gaap Assets
Assets
29092623 USD
CY2013Q4 us-gaap Assets
Assets
34835481 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
22614688 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
28174578 USD
CY2013 us-gaap Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1
AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1
59000 USD
CY2012 us-gaap Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1
AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1
11000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27351969 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21468269 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10747951 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19781976 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
500000 shares
us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P2Y
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9034025 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5883700 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10720318 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
4.41
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
694441 shares
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
778982 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36391191 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24645112 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
666666 shares
CY2007Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
270562 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
246451 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
363912 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
536118 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
671972 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
9600000 USD
CY2011 us-gaap Debt Issuance Costs
DebtIssuanceCosts
0 USD
CY2013 us-gaap Debt Issuance Costs
DebtIssuanceCosts
-177802 USD
CY2012 us-gaap Debt Issuance Costs
DebtIssuanceCosts
0 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
-177802 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1660679 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1527883 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3193809 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4800776 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
204319000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
212877000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1303000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
300000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
178966000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
177589000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12606000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
14230000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
13674000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12747000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
212577000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
203016000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
300000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1303000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
48000 USD
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
USD
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2011 us-gaap Depreciation
Depreciation
2200000 USD
CY2012 us-gaap Depreciation
Depreciation
1600000 USD
CY2013 us-gaap Depreciation
Depreciation
586000 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
586343 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1622736 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2252412 USD
CY2013 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2013, the FASB issued Accounting Standards Update No. 2013-02, "Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income", ("ASU 2013-02"). ASU 2013-02 requires entities to disclose items reclassified out of Accumulated Other Comprehensive Income ("AOCI") and into net income in their entirety, the effect of the reclassification on each affected net income line item, and, for AOCI reclassification items that are not reclassified in their entirety into net income, a cross reference to other required U.S. GAAP disclosures. This consolidated standard is effective for annual periods beginning after December 31, 2012 and interim periods within those years. The application of this standard did not have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists", ("ASU 2013-11"). ASU 2013-11 amends ASC 740, "Income Taxes", by providing guidance on the financial statement presentation of an unrecognized benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 does not affect the recognition or measurement of uncertain tax positions under ASC 740. ASU 2013-11 will be effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted. We do not expect the adoption of ASU 2013-11 to have any impact on our consolidated financial statements.</font></div></div>
CY2013 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3159782 USD
CY2011 us-gaap Dividends Preferred Stock
DividendsPreferredStock
790500 USD
CY2012 us-gaap Dividends Preferred Stock
DividendsPreferredStock
791735 USD
CY2011 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
790500 USD
CY2012 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
395250 USD
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.29
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2013Q1 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.127
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-292000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-37447 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11026 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-59110 USD
CY2012 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 USD
CY2011 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 USD
CY2013 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
355500 USD
CY2011 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3322657 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3322657 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11465092 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14483835 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10820187 USD
CY2012Q4 us-gaap Goodwill
Goodwill
2572203 USD
CY2013Q4 us-gaap Goodwill
Goodwill
2572203 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
agen Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P4Y
CY2013Q2 agen Contingent Royalty
ContingentRoyalty
19091000 USD
CY2011 us-gaap Interest Expense
InterestExpense
4210097 USD
CY2012 us-gaap Interest Expense
InterestExpense
4718037 USD
CY2013 us-gaap Interest Expense
InterestExpense
2427729 USD
CY2012 us-gaap Interest Paid
InterestPaid
1573554 USD
CY2011 us-gaap Interest Paid
InterestPaid
12458 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2944000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9561000 USD
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5033000 USD
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7912000 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10225000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3850000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
0 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
2192000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
0 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
640000 USD
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-169000 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
143000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
102000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
26000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
59000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-581000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-1182000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-1359000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
105667 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-181848 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
189638 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
552334 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-551134 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2707613 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1474171 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1531495 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4050 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6360 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16022 USD
CY2011 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-269713 USD
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1916467 USD
CY2012 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
542349 USD
CY2013 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-183473 USD
CY2011 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
591504 USD
CY2012 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-747982 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9637 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
112505 USD
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-168474 USD
CY2013 us-gaap Interest Paid
InterestPaid
579650 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
16022 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
23336 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
18787 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
7931 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000 USD
CY2013Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29092623 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34835481 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10295873 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4812988 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3518550 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
204088 USD
CY2013 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
5580124 USD
CY2011 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
0 USD
CY2012 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
0 USD
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
5580124 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7244348 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9811158 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25780165 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103442 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-363520 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29462 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19532945 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16248911 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1012602 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-23276175 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-30072669 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-11324771 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-6923000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5729000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-5441000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
6768000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-11142000 USD
CY2011 us-gaap Other Noncash Expense
OtherNoncashExpense
4167849 USD
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
3141475 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
1820787 USD
CY2013 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1299304 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1303855 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
66683 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
277927 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1365357 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1679671 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-5835000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-7319000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-5777000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33232451 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24066675 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12116506 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5927000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7121000 USD
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5639000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6570000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7370000 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5827000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8842000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11193000 USD
CY2009Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
1400000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2672759 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1941 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
110473 USD
CY2012 us-gaap Notes Assumed1
NotesAssumed1
0 USD
CY2011 us-gaap Notes Assumed1
NotesAssumed1
171640 USD
CY2013 us-gaap Notes Assumed1
NotesAssumed1
0 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-24980112 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-19086806 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-6740543 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14447000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1407000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1600000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1544000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1489000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1447000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6960000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
366000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
438000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
162997 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32156 USD
CY2013 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
450000 USD
CY2011 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23884 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30422000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30011000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2606428 USD
CY2011 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
790500 USD
CY2012 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
592875 USD
CY2011 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2012 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-100000 USD
CY2013 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-555556 USD
CY2012 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 USD
CY2011 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
38000000 USD
CY2011 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4998799 USD
CY2013 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2012 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103442 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
813520 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54547 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
658412 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
545907 USD
CY2011Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6300000 USD
CY2011 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
10000000 USD
CY2012 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000 USD
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000 USD
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
78574 USD
CY2013 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
104010 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
82536 USD
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10464203 USD
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
26462810 USD
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
7980375 USD
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5000000 USD
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2784845 USD
CY2013 us-gaap Revenues
Revenues
3045207 USD
CY2013 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
481000 USD
CY2014 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
365000 USD
CY2011 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
541000 USD
CY2012 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
399000 USD
CY2015 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
185000 USD
CY2011 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
10000000 USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10564195 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11022391 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13005366 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-649092036 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-619019367 USD
CY2011 us-gaap Revenues
Revenues
2755772 USD
CY2012 us-gaap Revenues
Revenues
15960716 USD
CY2012Q1 us-gaap Revenues
Revenues
13375000 USD
CY2012Q3 us-gaap Revenues
Revenues
869000 USD
CY2012Q2 us-gaap Revenues
Revenues
627000 USD
CY2012Q4 us-gaap Revenues
Revenues
1090000 USD
CY2013Q3 us-gaap Revenues
Revenues
736000 USD
CY2013Q1 us-gaap Revenues
Revenues
1109000 USD
CY2013Q2 us-gaap Revenues
Revenues
807000 USD
CY2013Q4 us-gaap Revenues
Revenues
393000 USD
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.68
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.00
CY2008Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2008Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1489821 USD
CY2011 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
0 USD
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1417864 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0149
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16694 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
47386 shares
CY2013Q4 us-gaap Security Deposit
SecurityDeposit
204000 USD
CY2012Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
35679232 USD
CY2013Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
0 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
4303961 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4127786 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
2646767 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
446 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
6.30
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
237552 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.70
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.99
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.38
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
339800 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.73
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.86502
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.03
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.96
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1482800 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.42
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.61
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2324 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.72
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2195726 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.33
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2138 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3946623 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.82
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.36
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.91
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.86
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.40
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1396 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2011Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2287581 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4503 shares
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
81098 USD
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
88880 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
52193 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7503375 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10464203 USD
CY2013 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
11275000 USD
CY2012 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2011 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4.51 USD
CY2012 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 USD
CY2013 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
2906664 USD
CY2011 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1438 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15130 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26381 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-17600157 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-4480703 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-14707212 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-20830965 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43490 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43490 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
324792 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
324792 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5533000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5649000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
78000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
38000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</font></div></div>
CY2013 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
291517 USD
CY2012 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
0 USD
CY2011 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
0 USD
CY2008Q1 agen Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P9Y6M
CY2009Q3 agen Class Of Warrant Or Right Non Exercisable Term
ClassOfWarrantOrRightNonExercisableTerm
P6M
CY2008Q1 agen Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P10Y
CY2012Q4 agen Clinical Trials
ClinicalTrials
291000 USD
CY2013Q4 agen Clinical Trials
ClinicalTrials
1021000 USD
CY2013 agen Clinical Trials Expense
ClinicalTrialsExpense
2720000 USD
CY2012 agen Clinical Trials Expense
ClinicalTrialsExpense
654000 USD
CY2011 agen Clinical Trials Expense
ClinicalTrialsExpense
623000 USD
CY2013Q4 agen Contingent Royalty
ContingentRoyalty
18799000 USD
CY2012Q4 agen Contingent Royalty
ContingentRoyalty
0 USD
CY2013 agen Contingent Royalty Consideration
ContingentRoyaltyConsideration
19091000 USD
CY2012 agen Conversion Of Notes Payable To Future Royalties
ConversionOfNotesPayableToFutureRoyalties
0 USD
CY2013 agen Conversion Of Notes Payable To Future Royalties
ConversionOfNotesPayableToFutureRoyalties
19090658 USD
CY2011 agen Conversion Of Notes Payable To Future Royalties
ConversionOfNotesPayableToFutureRoyalties
0 USD
CY2011 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
5580124 USD
CY2013 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
0 USD
CY2012 agen Convertible Note Adjustment To Equity For Conversion Option
ConvertibleNoteAdjustmentToEquityForConversionOption
0 USD
CY2013Q4 agen Cumulative Payments For Clinical Trials
CumulativePaymentsForClinicalTrials
49400000 USD
CY2012Q4 agen Deferredtaxassetscontingentroyaltyconsideration
Deferredtaxassetscontingentroyaltyconsideration
0 USD
CY2013Q4 agen Deferredtaxassetscontingentroyaltyconsideration
Deferredtaxassetscontingentroyaltyconsideration
7384000 USD
CY2011 agen Effect On Additional Paid In Capital Due To Note Amendment
EffectOnAdditionalPaidInCapitalDueToNoteAmendment
6335124 USD
CY2013Q4 agen Estimate Of Total Payments For Clinical Trials
EstimateOfTotalPaymentsForClinicalTrials
52600000 USD
CY2011 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
-28063 USD
CY2012 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
-38744 USD
CY2013 agen Financing Of Property And Equipment
FinancingOfPropertyAndEquipment
-53297 USD
CY2011 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
2829105 USD
CY2013 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
0 USD
CY2012 agen Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest
IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest
1499981 USD
CY2012 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-821000 USD
CY2011 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-1979000 USD
CY2013 agen Net Operating Loss Expirations
NetOperatingLossExpirations
-1778000 USD
CY2009Q1 agen New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Debt Discount
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnDebtDiscount
1300000 USD
CY2009Q1 agen New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Derivative Liability
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnDerivativeLiability
2700000 USD
CY2013Q4 agen Noncontrolling Interest
NoncontrollingInterest
0 USD
CY2012Q4 agen Noncontrolling Interest
NoncontrollingInterest
5580124 USD
CY2012Q4 agen Other Ltd
OtherLTD
34427 USD
CY2013Q4 agen Other Ltd
OtherLTD
5347690 USD
CY2011 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
755000 USD
CY2013 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
0 USD
CY2012 agen Reclassification Of Derivative Liability Into Equity
ReclassificationOfDerivativeLiabilityIntoEquity
0 USD
CY2011 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-78079 USD
CY2013 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-4347 USD
CY2012 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-31945 USD
CY2013 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
1627343 USD
CY2012 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
14470895 USD
CY2011 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
2755772 USD
CY2011 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
330000 USD
CY2012 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
2100000 USD
CY2013 agen Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue
1600000 USD
CY2013 agen Share Based Compensation Expense
ShareBasedCompensationExpense
4128000 USD
CY2011 agen Share Based Compensation Expense
ShareBasedCompensationExpense
2647000 USD
CY2012 agen Share Based Compensation Expense
ShareBasedCompensationExpense
4304000 USD
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
730994 shares
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
833333 shares
CY2008Q1 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1451450 shares
CY2008Q2 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1166666 shares
CY2011 agen Shares Issued In Private Placements Value
SharesIssuedInPrivatePlacementsValue
477000 USD
CY2007Q3 agen Stock Issued During Period Price Per Share
StockIssuedDuringPeriodPricePerShare
18.48
CY2013 agen Stock Issued During Periodfor Extinguishmentof Debt
StockIssuedDuringPeriodforExtinguishmentofDebt
12416689 USD
CY2010Q4 agen Subscription Agreement Terms Additional Purchase Option Exercise Period
SubscriptionAgreementTermsAdditionalPurchaseOptionExercisePeriod
P90D
CY2012 agen Terms Of Private Placement Subsequent Offering Potential Proceeds From Issuance Of Private Placement
TermsOfPrivatePlacementSubsequentOfferingPotentialProceedsFromIssuanceOfPrivatePlacement
575901 USD
CY2011 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2013 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2012 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
0 USD
CY2011 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
19898632 shares
CY2013 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
29765547 shares
CY2012 agen Weighted Average Number Of Shares Outstanding Basic And Diluted1
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1
23628903 shares
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001098972
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62173299 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
87100000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
AGENUS INC
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001445305-14-000937-index-headers.html Edgar Link pending
0001445305-14-000937-index.html Edgar Link pending
0001445305-14-000937.txt Edgar Link pending
0001445305-14-000937-xbrl.zip Edgar Link pending
agen-12312012x10k_charta01.jpg Edgar Link pending
agen-12312013x10k.htm Edgar Link pending
agen-20131231.xml Edgar Link completed
agen-20131231.xsd Edgar Link pending
agen-20131231_cal.xml Edgar Link unprocessable
agen-20131231_def.xml Edgar Link unprocessable
agen-20131231_lab.xml Edgar Link unprocessable
agen-20131231_pre.xml Edgar Link unprocessable
agen-exhibit108.htm Edgar Link pending
agen-exhibit21.htm Edgar Link pending
agen-exhibit232.htm Edgar Link pending
agen-exhibit3111.htm Edgar Link pending
agen-exhibit3121.htm Edgar Link pending
agen-exhibit3211.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending